MabSwitch
Pre-clinicalMabSwitch Inc. is a biotechnology company founded to develop and commercialize novel innovative products based on the groundbreaking invention of affinity switches for antibodies.
Founded
2016
Focus
Antibodies
About
MabSwitch Inc. is a biotechnology company founded to develop and commercialize novel innovative products based on the groundbreaking invention of affinity switches for antibodies.
Funding History
1Total raised: $250K
Grant$250KNIH SBIRSep 15, 2022
Company Info
TypePrivate
Founded2016
LocationSan Francisco, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile